Moretti, M.; Caraffi, R.; Lorenzini, L.; Ottonelli, I.; Sannia, M.; Alastra, G.; Baldassarro, V.A.; Giuliani, A.; Duskey, J.T.; Cescatti, M.;
et al. “Combo” Multi-Target Pharmacological Therapy and New Formulations to Reduce Inflammation and Improve Endogenous Remyelination in Traumatic Spinal Cord Injury. Cells 2023, 12, 1331.
https://doi.org/10.3390/cells12091331
AMA Style
Moretti M, Caraffi R, Lorenzini L, Ottonelli I, Sannia M, Alastra G, Baldassarro VA, Giuliani A, Duskey JT, Cescatti M,
et al. “Combo” Multi-Target Pharmacological Therapy and New Formulations to Reduce Inflammation and Improve Endogenous Remyelination in Traumatic Spinal Cord Injury. Cells. 2023; 12(9):1331.
https://doi.org/10.3390/cells12091331
Chicago/Turabian Style
Moretti, Marzia, Riccardo Caraffi, Luca Lorenzini, Ilaria Ottonelli, Michele Sannia, Giuseppe Alastra, Vito Antonio Baldassarro, Alessandro Giuliani, Jason Thomas Duskey, Maura Cescatti,
and et al. 2023. "“Combo” Multi-Target Pharmacological Therapy and New Formulations to Reduce Inflammation and Improve Endogenous Remyelination in Traumatic Spinal Cord Injury" Cells 12, no. 9: 1331.
https://doi.org/10.3390/cells12091331
APA Style
Moretti, M., Caraffi, R., Lorenzini, L., Ottonelli, I., Sannia, M., Alastra, G., Baldassarro, V. A., Giuliani, A., Duskey, J. T., Cescatti, M., Ruozi, B., Aloe, L., Vandelli, M. A., Giardino, L., Tosi, G., & Calzà , L.
(2023). “Combo” Multi-Target Pharmacological Therapy and New Formulations to Reduce Inflammation and Improve Endogenous Remyelination in Traumatic Spinal Cord Injury. Cells, 12(9), 1331.
https://doi.org/10.3390/cells12091331
